Ofipharma

Ofipharma is a Dutch pharmaceutical company that specializes in the sourcing, development, and distribution of Active Pharmaceutical Ingredients (APIs) for human and veterinary applications. The company provides a comprehensive range of services including regulatory support, quality control, and custom manufacturing through its GMP-certified facilities. Ofipharma serves as a critical link in the pharmaceutical supply chain, ensuring the availability of high-quality raw materials for drug manufacturers worldwide. In early 2024, Ofipharma was acquired by Barentz, a global leader in life science ingredients, to strengthen its position in the pharmaceutical market. The company is recognized for its expertise in navigating complex regulatory environments and maintaining rigorous quality standards.